Body computed tomography in sepsis: predictors of CT findings and patient outcomes in a retrospective medical ICU cohort study.


Journal

Emergency radiology
ISSN: 1438-1435
Titre abrégé: Emerg Radiol
Pays: United States
ID NLM: 9431227

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 20 05 2022
accepted: 28 07 2022
pubmed: 4 8 2022
medline: 11 11 2022
entrez: 3 8 2022
Statut: ppublish

Résumé

Sepsis is a life-threatening condition that requires immediate focus identification and control. However, international sepsis guidelines do not provide information on imaging choice. To identify predictors of CT findings and patient outcomes in a population of septic patients from a medical ICU. A full-text search in the radiological information system (RIS) retrieved 227 body CT examinations conducted to identify infectious sources in 2018. CT reports were categorized according to identified foci and their diagnostic certainty. Diagnostic accuracy of CT was compared to microbiological results. Clinical and laboratory information was gathered. Statistical analysis was performed using nonparametric tests and logistic regression analysis. CT revealed more positive infectious foci 52.4% (n = 191/227) than microbiological tests 39.3% (n = 79/201). There were no significant differences between focus-positive CT scans with regard to positive microbiological testing (p = 0.32). Sequential organ failure assessment (SOFA) scores were slightly but nonsignificantly higher in patients with a focus-positive CT, odds ratio (OR) = 0.999 (95% CI 0.997-1.001) with p = 0.52. Among C-reactive protein (CRP), procalcitonin (PCT), and leukocytes, in focus-positive versus focus-negative CT scans, CRP showed a minor but statistically significant elevation in the group with focus-positive CT scans (OR = 1.004, 95% CI = 1.000-1.007, p = 0.04). No significant association was found for PCT (OR = 1.007, 95% CI = 0.991-1.023; p = 0.40) or leukocytes (OR = 1.003, 95% CI = 0.970-1.038; p = 0.85). In 33.5% (n = 76/227) of cases, the CT findings had at least one therapeutic consequence. In 81.6% (n = 62/76), the CT findings resulted in one consequence, in 14.5% (n = 11/76) in two consequences, and in 3.9% (n = 3/76) in three consequences. There was no significant association between focus-positive CT scans and mortality (p = 0.81). In this population of septic patients in medical intensive care, microbiological analysis complemented CT findings. Both clinical and laboratory parameters were not predictive of CT findings. While therapeutic consequences of CT findings in this study population underline the role of CT for decision making in septic patients, CT findings do not predict patient outcomes in this retrospective analysis.

Sections du résumé

BACKGROUND BACKGROUND
Sepsis is a life-threatening condition that requires immediate focus identification and control. However, international sepsis guidelines do not provide information on imaging choice.
PURPOSE OBJECTIVE
To identify predictors of CT findings and patient outcomes in a population of septic patients from a medical ICU.
MATERIAL AND METHODS METHODS
A full-text search in the radiological information system (RIS) retrieved 227 body CT examinations conducted to identify infectious sources in 2018. CT reports were categorized according to identified foci and their diagnostic certainty. Diagnostic accuracy of CT was compared to microbiological results. Clinical and laboratory information was gathered. Statistical analysis was performed using nonparametric tests and logistic regression analysis.
RESULTS RESULTS
CT revealed more positive infectious foci 52.4% (n = 191/227) than microbiological tests 39.3% (n = 79/201). There were no significant differences between focus-positive CT scans with regard to positive microbiological testing (p = 0.32). Sequential organ failure assessment (SOFA) scores were slightly but nonsignificantly higher in patients with a focus-positive CT, odds ratio (OR) = 0.999 (95% CI 0.997-1.001) with p = 0.52. Among C-reactive protein (CRP), procalcitonin (PCT), and leukocytes, in focus-positive versus focus-negative CT scans, CRP showed a minor but statistically significant elevation in the group with focus-positive CT scans (OR = 1.004, 95% CI = 1.000-1.007, p = 0.04). No significant association was found for PCT (OR = 1.007, 95% CI = 0.991-1.023; p = 0.40) or leukocytes (OR = 1.003, 95% CI = 0.970-1.038; p = 0.85). In 33.5% (n = 76/227) of cases, the CT findings had at least one therapeutic consequence. In 81.6% (n = 62/76), the CT findings resulted in one consequence, in 14.5% (n = 11/76) in two consequences, and in 3.9% (n = 3/76) in three consequences. There was no significant association between focus-positive CT scans and mortality (p = 0.81).
CONCLUSION CONCLUSIONS
In this population of septic patients in medical intensive care, microbiological analysis complemented CT findings. Both clinical and laboratory parameters were not predictive of CT findings. While therapeutic consequences of CT findings in this study population underline the role of CT for decision making in septic patients, CT findings do not predict patient outcomes in this retrospective analysis.

Identifiants

pubmed: 35922682
doi: 10.1007/s10140-022-02083-9
pii: 10.1007/s10140-022-02083-9
pmc: PMC9643202
doi:

Substances chimiques

Procalcitonin 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

979-985

Informations de copyright

© 2022. The Author(s).

Références

Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863
pubmed: 28345952
Intensive Care Med. 2007 Mar;33(3):435-43
pubmed: 17225161
Crit Care Med. 2006 Feb;34(2):344-53
pubmed: 16424713
JAMA. 1996 Feb 14;275(6):470-3
pubmed: 8627969
BMJ. 2016 May 23;353:i1585
pubmed: 27217054
Ann Transl Med. 2016 Sep;4(17):330
pubmed: 27713888
Crit Care Med. 2006 Jan;34(1):15-21
pubmed: 16374151
Acta Radiol. 1999 Sep;40(5):552-5
pubmed: 10485247
Clin Radiol. 2022 Mar;77(3):203-209
pubmed: 34872706
Eur J Radiol. 2020 Nov;132:109325
pubmed: 33027726
Clin Imaging. 2021 Jan;69:223-227
pubmed: 32971451
Acta Anaesthesiol Scand. 2008 Apr;52(4):547-52
pubmed: 18261200
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Eur Radiol. 2017 Nov;27(11):4544-4551
pubmed: 28608164
J Crit Care. 2015 Apr;30(2):386-9
pubmed: 25468363
Scand J Infect Dis. 2009;41(6-7):469-79
pubmed: 19452348
Biomed Res Int. 2016;2016:5941279
pubmed: 27777948

Auteurs

Julian Pohlan (J)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany. julian.pohlan@charite.de.
Berlin Institute of Health at Charité -Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany. julian.pohlan@charite.de.

Denis Witham (D)

Department of Cardiology With Intensive Care, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Lara Farkic (L)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Melina Anhamm (M)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Alexandra Schnorr (A)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Gloria Muench (G)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Karim Breiling (K)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Robert Ahlborn (R)

Department of Information Technology, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Enrico Herz (E)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Kerstin Rubarth (K)

Berlin Institute of Health at Charité -Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.
Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.

Damaris Praeger (D)

Department of Cardiology With Intensive Care, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Marc Dewey (M)

Department of Radiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Campus Charité Mitte, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH